Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Suven Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
543064
INE03QK01018
86.6610444
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
SUVENPHAR
133.3
32949.62
EPS(TTM)
Face Value(
)
Div & Yield %:
9.71
1
0
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
1024.99
1330.08
1320.22
1009.72
833.79
377.83
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1024.99
1330.08
1320.22
1009.72
833.79
377.83
Other Income
55.09
44.55
187.79
14.24
18.12
0.60
Stock Adjustments
-53.88
20.94
60.35
8.37
11.05
21.32
Total Income
1026.20
1395.57
1568.36
1032.33
862.96
399.75
EXPENDITURE :
Raw Materials
248.38
421.36
459.46
310.32
240.24
124.52
Power & Fuel Cost
46.16
71.35
59.55
44.20
38.24
18.06
Employee Cost
126.88
108.58
100.48
76.23
65.10
29.63
Other Manufacturing Expenses
83.19
101.96
115.25
90.76
66.49
33.83
Selling & Administrative Expenses
38.85
43.57
52.62
44.93
44.72
16.23
Miscellaneous Expenses
17.75
13.50
10.92
8.61
5.26
5.34
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
561.21
760.33
798.29
575.05
460.05
227.60
Operating Profit
465.00
635.24
770.08
457.28
402.91
172.15
Interest
7.43
12.75
8.53
11.66
21.81
2.79
Gross Profit
457.57
622.49
761.55
445.62
381.10
169.36
Depreciation
48.79
43.10
39.10
31.64
23.51
11.50
Profit Before Tax
408.78
579.39
722.45
413.98
357.59
157.86
Tax
97.37
142.45
157.63
101.72
88.81
33.17
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
6.59
4.34
6.72
3.62
-1.30
15.42
Reported Net Profit
304.82
432.60
558.10
308.65
270.08
109.27
Extraordinary Items
32.53
10.55
14.53
2.51
4.73
0.11
Adjusted Net Profit
272.29
422.05
543.57
306.14
265.35
109.16
Adjustment below Net Profit
-0.30
-0.26
-0.76
-0.84
-13.90
315.80
P & L Balance brought forward
1490.07
1276.39
835.88
568.52
390.98
0.00
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
218.65
116.83
40.46
78.64
34.09
P & L Balance carried down
1794.59
1490.07
1276.39
835.88
568.52
390.98
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
0.00
600.00
500.00
200.00
500.00
0.00
Dividend Per Share(Rs)
0.00
6.00
5.00
2.00
5.00
0.00
Earnings Per Share-Unit Curr
11.97
16.99
21.92
12.12
21.22
20.60
Earnings Per Share(Adj)-Unit Curr
11.97
16.99
21.92
12.12
10.61
20.60
Book Value-Unit Curr
80.76
68.72
59.74
41.84
61.50
0.00
Book Value(Adj)-Unit Curr
80.76
68.72
59.74
41.84
30.75
0.00